Table 4.
Comparison of Clinical Characteristics, Laboratory Parameters, and Liver Disease Severity Scores Among Cirrhosis Patients With Covid-19 Infection Whom We Could or Failed to Contact for Follow-Up.
| Clinical characteristics | Failed to contact on follow-up (n = 28) | Contacted on follow-up (n = 92) | P-value |
|---|---|---|---|
| Age (years) | 45 (33–52) | 46 (38–54) | 0.260 |
| Sex, male n (%) | 24 (85.7%) | 73 (79.3%) | 0.588 |
| Diabetes | 20 (21.7%) | ||
| Etiology of cirrhosis | 0.077 | ||
| Alcohol | 18 (64.3%) | 38 (41.3%) | |
| HBV | 0 | 7 (7.6%) | |
| HCV | 2 (7.1%) | 9 (9.8%) | |
| AIH | 1 (3.6%) | 8 (8.7%) | |
| NAFLD | 1 (3.6%) | 10 (10.9%) | |
| cryptogenic | 2 (7.1%) | 16 (17.4%) | |
| Others | 4 (14.3%) | 4 (4.3%) | |
| Etiology | 0.050 | ||
| Alcohol | 18 (64.3%) | 38 (41.3%) | |
| Others | 10 (35.7%) | 54 (58.7%) | |
| Hemoglobin (g/dL) | 8.7 (7.4–8.9) | 8.5 (7.3–10.2) | 0.876 |
| TLC (per mm3) | 5600 (2500–9000) | 5100 (3225–7975) | 0.805 |
| Platelet count ( × 103/mm3) | 72 (47–131) | 69 (49–106) | 0.871 |
| INR | 1.4 (1.2–2.2) | 1.5 (1.2–1.8) | 0.747 |
| Total bilirubin (mg/dL) | 2.9 (1.1–6.5) | 1.8 (0.9–4.0) | 0.131 |
| Creatinine (mg/dl) | 0.9 (0.6–1.3) | 0.8 (0.6–1.1) | 0.356 |
| AST (IU/L) | 49 (39–80) | 51 (36–72) | 0.695 |
| ALT (IU/L) | 30 (22–42) | 31 (24–47) | 0.644 |
| Alk P (IU/L) | 101 (69–134) | 117 (78–142) | 0.487 |
| Albumin (g/dL) | 2.8 (2.3–3.2) | 2.8 (2.4–3.1) | 0.462 |
| CTP score | 9 (7–10) | 8 (6–10) | 0.272 |
| CTP class | 0.463 | ||
| A | 5 (17.9%) | 27 (29.3%) | |
| B | 13 (46.4%) | 39 (42.4%) | |
| C | 10 (35.7%) | 26 (28.3%) | |
| MELD | 18.0 (11.6–27.9) | 13.9 (10.6–20.2) | 0.087 |
| COVID severity | 0.798 | ||
| Mild | 22 (78.6%) | 76 (82.6%) | |
| Moderate | 4 (14.3%) | 9 (9.8%) | |
| Severity | 2 (7.1%) | 7 (7.6%) | |
Qualitative and quantitative data are expressed as proportions and median (interquartile range), respectively.
Abbreviations: AIH, autoimmune hepatitis; HBV, hepatitis B virus; HCV, hepatitis C virus; NAFLD, nonalcoholic fatty liver disease; TLC, Total leukocyte count; INR, international normalized ratio; ALT, alanine aminotransferase; Alk P, alkaline phosphatase; AST, aspartate aminotransferase; CTP, Child-Turcotte-Pugh; MELD, model for end-stage liver disease.